Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: Long-term follow-up data from EDITA study

Introduction: In the EDITA trial, patients with systemic sclerosis (SSc) and mild pulmonary vascular disease (PVD) treated with ambrisentan had a significant decline of pulmonary vascular resistance (PVR) but not of mean pulmonary arterial pressure (mPAP) vs. placebo after six months [ref:1]. [for full text, please go to the a.m. URL]

Institutions

Publication Details

Journal
German Medical Science (German Research Foundation)
Published
2024-09-18
DOI
https://doi.org/10.3205/24dgrh227
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: Long-term follow-up data from EDITA study

German Medical Science (German Research Foundation)
Pulmonary Hypertension Research and Treatments
article

Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: Long-term follow-up data from EDITA study

article en

Abstract

Introduction: In the EDITA trial, patients with systemic sclerosis (SSc) and mild pulmonary vascular disease (PVD) treated with ambrisentan had a significant decline of pulmonary vascular resistance (PVR) but not of mean pulmonary arterial pressure (mPAP) vs. placebo after six months [ref:1]. [for full text, please go to the a.m. URL]

German Medical Science (German Research Foundation)
Heidelberg University (DE), The Royal Free Hospital (GB), University Hospital Heidelberg (DE), Chirurgische Universitätsklinik Heidelberg (DE), University College London (GB)
Good health and well-being
Openalex Percentile: Top 51%
Pulmonary Hypertension Research and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: Long-term follow-up data from EDITA study · German Medical Science (German Research Foundation) (2024) | TGRS Research Map | TGRS